A A A
Feed icon

IHA news

Congratulations to Dr Teresa Niccoli on her paper in Current Biology

Congratulations to Dr Teresa Niccoli whose paper "Increased Glucose Transport into Neurons Rescues Ab Toxicity in Drosophila" has just been published in Current Biology by Cell Press. More...

Published: Aug 17, 2016 3:05:35 PM

ARUK funded post-doc position available at the IHA

The Institute of Healthy Ageing is currently seeking a post-doctoral research associate to work on the following ARUK-funded project.

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating, mid-life, neurodegenerative disorders for which no cure is currently available. Large expansions of a hexanucleotide GGGGCC-repeat in the first intron of the C9orf72 gene is the most common genetic cause of both ALS and FTD. We recently developed novel Drosophila models of C9orf72 repeat-induced neurodegeneration (Mizielinska et al Science 2014, 345:1192-1194).

This 3-year post-doctoral position will build on this work by investigating disease mechanisms in a range of C9orf72 fly lines using several approaches including genome-wide transcriptomic and translational analyses in both flies and iPSC-neurons. You will work as part of a collaborative team of investigators in the excellent and supportive scientific research community of UCL.

The post is funded for 3 years in the first instance by Alzheimer’s Research UK and is available from October 2016.

For full information and to apply please visit the UCL website at https://goo.gl/E5vk8j
More...

Published: Aug 11, 2016 2:27:25 PM

Lectureship for Alexandre Benedetto

Until recently an EU-funded postdoc in David Gems's lab, Alex Benedetto will shortly set up his own laboratory at the University of Lancaster, in the Department of Biomedical and Life Sciences. There he will continue his investigations of the biology of ageing in model organisms, particularly C. elegans. We wish Alex all the best in setting up his new lab! More...

Published: Jul 20, 2016 2:10:01 PM

About us


The Institute of Healthy Ageing (Director: Prof Dame Linda Partridge, DBE, FRS, FRSE, FMedSci) is an interdisciplinary centre of excellence for research on the biology of ageing and ageing-related diseases. The biological process of ageing contributes to increased risk of a wide range of diseases, from neurodegenerative diseases (e.g. Alzheimer's and Parkinson's disease) and cancer to cardiovascular disease (causing heart attack and stroke) and age-related macular degeneration (causing blindness in the elderly).

Our primary purpose is to bring together researchers working on the basic biology of ageing (biogerontology) with those working to understand the causes of ageing-related disease. By merging the two, we aim to develop a new translational biogerontology using the ageing process as a point of intervention to protect against the diseases of old age. Our goal is to improve the health and quality of life for older people.

The work of the Institute of Healthy Ageing is pursuing these ends by:

  • Conducting world class research on the biology of ageing and ageing-related disease
  • Increasing capacity in research on the biology of ageing by training new researchers and nurturing the work of younger principal investigators
  • Teaching about the biology of ageing at undergraduate and postgraduate levels

The problem of ageing is not just an issue of biology, but also of social science, economics and the built environment. A secondary aim of the Institute is to nurture broader collaborations across UCL between researchers working on different aspects of ageing.

We aim, through our combined activities, to transform healthcare technology and the social conditions of the elderly to create a future society in which the lives of older people are healthy, meaningful and happy. 

Our facilities are shared with the associated Bähler Lab, headed by Professor Jürg Bähler.

Page last modified on 05 nov 15 14:26